Tocqueville Asset Management’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.05M | Sell |
|
|||||
|
2025
Q1 | $7.72M | Buy |
|
|||||
|
2024
Q4 | $6.14M | Sell |
|
|||||
|
2024
Q3 | $7.26M | Sell |
|
|||||
|
2024
Q2 | $8.84M | Sell |
|
|||||
|
2024
Q1 | $9.38M | Buy |
|
|||||
|
2023
Q4 | $8.83M | Sell |
|
|||||
|
2023
Q3 | $7.37M | Sell |
|
|||||
|
2023
Q2 | $8.4M | Sell |
|
|||||
|
2023
Q1 | $8.72M | Buy |
|
|||||
|
2022
Q4 | $9.36M | Sell |
|
|||||
|
2022
Q3 | $9.07M | Sell |
|
|||||
|
2022
Q2 | $8.87M | Buy |
|
|||||
|
2022
Q1 | $10.3M | Buy |
|
|||||
|
2021
Q4 | $10.2M | Buy |
|
|||||
|
2021
Q3 | $9.85M | Buy |
|
|||||
|
2021
Q2 | $8.83M | Buy |
|
|||||
|
2021
Q1 | $6.36M | Buy |
|
|||||
|
2020
Q4 | $6.5M | Sell |
|
|||||
|
2020
Q3 | $5.15M | Sell |
|
|||||
|
2020
Q2 | $13.6M | Sell |
|
|||||
|
2020
Q1 | $11.3M | Sell |
|
|||||
|
2019
Q4 | $14.6M | Buy |
|
|||||
|
2019
Q3 | $11.1M | Buy |
|
|||||
|
2019
Q2 | $11.9M | Sell |
|
|||||
|
2019
Q1 | $12.3M | Sell |
|
|||||
|
2018
Q4 | $10.7M | Buy |
|
|||||
|
2018
Q3 | $8.69M | Buy |
|
|||||
|
2018
Q2 | $8.39M | Sell |
|
|||||
|
2018
Q1 | $8.15M | Buy |
|
|||||
|
2017
Q4 | $1.92M | Buy |
|
|||||
|
2017
Q3 | $1.9M | Buy |
|
|||||
|
2017
Q2 | $1.67M | Buy |
|
|||||
|
2017
Q1 | $1.12M | Buy |
|
|||||
|
2016
Q4 | $934K | Sell |
|
|||||
|
2016
Q3 | $1.18M | Sell |
|
|||||
|
2016
Q2 | $970K | Hold |
|
|||||
|
2016
Q1 | $927K | Hold |
|
|||||
|
2015
Q4 | $1.26M | Sell |
|
|||||
|
2015
Q3 | $1.16M | Hold |
|
|||||
|
2015
Q2 | $1.56M | Sell |
|
|||||
|
2015
Q1 | $1.41M | Hold |
|
|||||
|
2014
Q4 | $1.17M | Buy |
|
|||||
|
2014
Q3 | – | Sell |
|
|||||
|
2014
Q2 | $2.67M | Buy |
|
|||||
|
2013
Q4 | – | Sell |
|
|||||
|
2013
Q3 | $3.92M | Sell |
|
|||||
|
2013
Q2 | $3.69M | Buy |
|